Cargando…
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors
Glioblastomas (GBM), the most common malignant primary adult brain tumors, are uniformly lethal and are in need of improved therapeutic modalities. GBM contain extensive regions of hypoxia and are enriched in therapy resistant brain tumor-initiating cells (BTICs). Carbonic anhydrase 9 (CA9) is a hyp...
Autores principales: | Tatari, Nazanin, Zhang, Xiaoyu, Chafe, Shawn C., McKenna, Dillon, Lawson, Keith A., Subapanditha, Minomi, Shaikh, Muhammad Vaseem, Seyfrid, Mathieu, Savage, Neil, Venugopal, Chitra, Moffat, Jason, Singh, Sheila K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296860/ https://www.ncbi.nlm.nih.gov/pubmed/35874663 http://dx.doi.org/10.3389/fimmu.2022.905768 |
Ejemplares similares
-
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
por: Seyfrid, Mathieu, et al.
Publicado: (2022) -
UPAR AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN RECURRENT GLIOBLASTOMA
por: Maich, William, et al.
Publicado: (2023) -
An HLA-G/SPAG9/STAT3 axis promotes brain metastases
por: Bassey-Archibong, Blessing Iquo, et al.
Publicado: (2023) -
47. UNCOVERING A NOVEL ROLE FOR HLA-G IN BRAIN METASTASES
por: Bassey-Archibong, Blessing, et al.
Publicado: (2020) -
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence
por: Bakhshinyan, David, et al.
Publicado: (2021)